Science
GPT-Rosalind: OpenAI's AI Shot at Cracking Biology's Code
OpenAI's new GPT-Rosalind model promises to slash the grind of life sciences research, from drug discovery to genomics. Here's why this biology-tuned powerhouse could rewrite the rules of the lab.

The Signal
OpenAI has unleashed GPT-Rosalind, a frontier reasoning model laser-focused on life sciences. Announced on their blog yesterday, this isn't some off-the-shelf chatbot—it's named after Rosalind Franklin, the X-ray wizard whose overlooked snapshots helped unlock DNA's double helix. Built to supercharge drug discovery, genomics analysis, protein reasoning, and everyday research workflows, it's already stirring buzz in labs worldwide, per Ars Technica and VentureBeat reports.
Zoom...
OpenAI
GPT-Rosalind
AI
life sciences
drug discovery
genomics
biology
biotech
Share